Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia

Clinical Biochemistry

Volumn 37, Issue 11, 2004, Pages 990-996

  Sarandöl, Emre ^a   Şafak, Özlem ^a   Dirican, Melahat ^a   Uncu, Gürkan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Arylesterase; Lipoprotein oxidation; Malondialdehyde; Paraoxonase; Preeclampsia

Indexed keywords

APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; COPPER; LIPID; LIPOPROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; ASSAY; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EVALUATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; ISOLATION PROCEDURE; LIPID PEROXIDATION; MEASUREMENT; OXIDATION; PEROXIDATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SPECTROPHOTOMETRY;

APOLIPOPROTEINS B; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; COPPER; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS; MALONDIALDEHYDE; OXIDATION-REDUCTION; PRE-ECLAMPSIA; PREGNANCY;

EID: 6344220183     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.06.013     Document Type: Article

References (48)

1. J.M. Roberts, and C.W. Redman Pre-eclampsia: more than pregnancy-induced hypertension Lancet 341 1993 1447 1451
2. J.M. Roberts Endothelial dysfunction in preeclampsia Semin. Reprod. Endocrinol. 16 1998 5 15
3. E. Gratacos, E. Casals, R. Deulofeu, V. Cararach, P.L. Alonso, and A. Fortuny Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy Am. J. Obstet. Gynecol. 178 1998 1072 1076
4. J.M. Potter, and P.J. Nestel The hyperlipidemia of pregnancy in normal and complicated pregnancies Am. J. Obstet. Gynecol. 133 1979 165 170
5. C.A. Hubel, M.K. McLaughlin, R.W. Evans, B.A. Hauth, C.S. Sims, and J.M. Roberts Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum Am. J. Obstet. Gynecol. 174 1996 975 982
6. L. Belo, M. Caslake, D. Gaffney, A. Santos-Silva, L. Pereira-Leite, and A. Quintanilha Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies Atherosclerosis 162 2002 425 432
7. N. Sattar, A. Bendomir, C. Berry, J. Shepherd, I.A. Greer, and C.J. Packard Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis Obstet. Gynecol. 89 1997 403 408
8. G.K. Goode, J.P. Miller, and A.M. Heagerty Hyperlipidemia, hypertension and coronary heart disease Lancet 345 1995 362 364
9. N.A. Flavahan Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying in EDRF/nitric oxide activity Circulation 85 1992 1927 1938
10. C.A. Hubel Oxidative stress in the pathogenesis of preeclampsia Exp. Biol. Med. 222 1999 222 235
11. Z. Serdar, E. Gür, M. Colakoǧullari, O. Develioǧlu, and E. Sarandöl Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia Arch. Gynecol. Obstet. 268 2003 19 25
12. A. Var, N.K. Ku̧cu, F. Koyuncu, B.S. Uyanik, E. Onur, and Y. Yildirim Atherogenic profile in preeclampsia Arch. Gynecol. Obstet. 268 2003 45 47
13. Y. Wang, S.W. Walsh, J. Guo, and J. Zhang The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood Am. J. Obstet. Gynecol. 165 1991 1695 1700
14. J.T. Uotila, R.J. Tuimala, and T.M. Aarnio Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy Br. J. Obstet. Gynecol. 100 1993 270 276
15. M.B. Cekmen, A.B. Erbagci, A. Balat, C. Duman, H. Maral, and K. Ergen Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension Clin. Biochem. 36 2003 575 578
16. E. Gratacos Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease Eur. J. Obstet. Gynecol. Reprod. Biol. 92 2000 63 66
17. H. Esterbauer, J. Gebicki, H. Puhl, and G. Jurgens The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Radical Biol. Med. 13 1992 341 390
18. M.C. Jong, W.L. Hendriks, L.C. Van Vark, V.E. Dahlmans, J.E. Groener, and L.M. Havekas Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis Arterioscler., Thromb., Vasc. Biol. 20 2000 144 151
19. S.C. Whitman, C.G. Sawyez, D.B. Miller, B.M. Wolfe, and M.W. Huff Oxidized type IV hypertriglyceridemic VLDLâ€"Remnants cause greater macrophage cholesterol accumulation than oxidized LDL J. Lipid Res. 39 1998 1008 1020
20. S.T. Davidge, A.P. Signorella, C.A. Hubel, D.L. Kykins, and J.M. Roberts Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin Hypertension 28 1996 758 764
21. K. Winkler, B. Wetzka, M.A. Hoffmann, I. Friedrich, M. Kinner, and M.W. Baumstark Triglyceride-rich lipoproteins are associated with hypertension in preeclampsia J. Clin. Endocrinol. Metab. 88 2003 1162 1166
22. M. Aviram, M. Rosenblat, and C.L. Bisgaier Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase J. Clin. Invest. 101 1998 1581 1590
23. M.I. Mackness, S. Arrol, X. Abbot, and P.N. Durrington Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase Atherosclerosis 104 1993 129 135
24. K.N. Gan, A. Smolen, H.W. Eckerson, and B.N. La Du Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities Drug Metab. Dispos. 19 1991 100 106
25. H. Cao, A. Girard-Globa, F. Berthezene, and P. Moulin Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-R polymorphism J. Lipid Res. 40 1999 133 139
26. A. Ayub, M.I. Mackness, S. Arrol, B. Mackness, J. Patel, and P.N. Durrinton Serum paraoxonase after myocardial infarction Arterioscler. Thromb. Vasc. Biol. 19 1999 330 335
27. M.I. Mackness, D. Harty, D. Bhatnagar, P.H. Winocour, S. Arrol, and M. Ishola Serum paraoxonase activity in familial hypercholesterolaemia and insulin dependent diabetes mellitus Atherosclerosis 86 1991 193 199
28. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
29. H.W. Eckerson, M.C. Wyte, and B.N. La Du The human serum paraoxonase/arylesterase polymorphism Am. J. Hum. Genet. 35 1983 1126 1138
30. L. Haagen, and A. Brock A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate Eur. J. Clin. Chem. Clin. Biochem. 30 1992 391 395
31. I.S. Young, and E.R. Trimble Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorometric detection Ann. Clin. Biochem. 28 1991 504 508
32. A. Zhang, J. Vertommen, L. Van Gaal, and I. De Leeuw A rapid and simple method for measuring the susceptibility of low-density lipoprotein and very-low-density lipoprotein to copper-catalyzed oxidation Clin. Chim. Acta 227 1993 159 173
33. L. Mosca, M. Rubenfire, T. Tarshis, A. Tsai, and T. Pearson Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease Am. J. Cardiol. 80 1997 825 830
34. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 52 1978 302 310
35. J.M.C. Gutteridge, and G.J. Quinlan Malondialdehyde formation from lipid peroxides in the thiobarbituric acid test: the role of lipid radicals, iron salts and metal chelators J. Appl. Biochem. 5 1983 293 299
36. A. Wakatsuki, N. Ikenoue, Y. Okatani, K. Shinohara, and T. Fukaya Lipoprotein particles in preeclampsia: susceptibility to oxidative modification Obstet. Gynecol. 96 2000 55 59
37. D.W. Branch, M.D. Mitchell, E. Miller, W. Palinski, and J.L. Witztum Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein Lancet 343 1994 645 646
38. J. Uotila, T. Solakivi, O. Jaakkola, R. Tuimala, and T. Lehtimaki Antibodies against copper oxidised and malondialdehyde modified low density lipoproteins in pre-eclampsia pregnancies Br. J. Obstet. Gynaecol. 105 1998 1113 1117
39. O. Fainaru, D. Lichtenberg, I. Pinchuk, B. Almog, R. Gamzu, and M. Kupfermine Preeclampsia is associated with increased susceptibility of serum lipids to copper-induced peroxidation in vitro Acta Obstet. Gynecol. Scand. 82 2003 711 715
40. D.L. Tribble, L.G. Holl, P.D. Wood, and R.M. Krauss Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size Atherosclerosis 93 1992 189 199
41. H.F. Hoff, J. O'Neil, and A. Yashiro Partial characterization of lipoproteins containing apo(a) in human atherosclerotic lesions J. Lipid Res. 34 1993 789 798
42. J.W. Meekins, R. Pijnenborg, M. Hanssens, A. van Assche, and I.R. McFadyen Immunohistochemical detection of lipoprotein(a) in the wall of bed spiral arteries in normal and severe preeclamptic pregnancies Placenta 15 1994 511 524
43. S. Djurovic, R. Schjetlein, F. Wisloff, G. Haugen, H. Husby, and K. Berg Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia Clin. Genet. 52 1997 371 376
44. J. Wang, S. Mimuro, R. Lahoud, B. Trudinger, and X.L. Wang Elevated levels of lipoprotein(a) in women with preeclampsia Am. J. Obstet. Gynecol. 178 1998 146 149
45. R.S. Bowen, J. Moodley, M.F. Dutton, and A. Theron Oxidative stress in pre-eclampsia Acta Obstet. Gynecol. Scand. 80 2001 719 725
46. U. Rosing, G. Samsioe, O. Olund, B. Johansson, and A. Kallner Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy complicated by pre-eclampsia Horm. Metab. Res. 21 1989 376 382
47. S. Kobayashi, M. Tanaka, K. Masaki, S. Hirakawa, and K. Momose Apolipoprotein levels in preeclamptic pregnancies Nippon Sanka Fujinka Gakkai Zasshi 44 1992 223 228
48. S. Kumru, S. Aydin, M.F. Gursu, and Z. Ozcan Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclampsia women Eur. J. Obstet. Gynecol. 114 2004 177 181